177A — Kohjin Bio Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Kohjin Bio, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 922 | 1,244 | 636 | 1,015 | 332 |
| Depreciation | |||||
| Non-Cash Items | 69.1 | 39.2 | -42.4 | -80.5 | 9.88 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -407 | -990 | -69.2 | -380 | -39.8 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 763 | 461 | 824 | 916 | 699 |
| Capital Expenditures | -204 | -561 | -563 | -887 | -979 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 286 | -14.7 | -14.6 | -203 | 112 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 82.8 | -575 | -577 | -1,091 | -868 |
| Financing Cash Flow Items | -33.9 | -41.6 | -79.1 | -15.6 | -1 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -360 | -172 | -1.35 | 1,376 | -321 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 515 | -272 | 264 | 1,222 | -463 |